Focus
- Volume 13
- Number 3
- July 2015
Clinical Synthesis
Publication date: 01 July 2015
Pages267–282The 2011 Institute of Medicine report Relieving Pain in America estimates that 100 million adult Americans are affected by chronic pain, costing a staggering $560 billion to $635 billion annually. In the context of this immense personal and socioeconomic ...
https://doi.org/10.1176/appi.focus.130301Publication date: 01 July 2015
Pages283–289Since their discovery, psychostimulant drugs (amphetamine, dextroamphetamine, and methylphenidate) have been used to treat a wide a variety of conditions. The pharmacologic effects of these drugs include facilitation of monoaminergic neurotransmission. ...
https://doi.org/10.1176/appi.focus.130302Publication date: 01 July 2015
Pages290–306Tobacco use disorder is the most common substance use disorder among individuals with any other psychiatric disorder, resulting in enormous health disparities, shorter lifespan, increased suicide risk, and reduced quality of life compared with others, due ...
https://doi.org/10.1176/appi.focus.20150008Publication date: 01 July 2015
Pages307–316The recreational and medicinal desirability of marijuana (Cannabis sativa), fomented by widespread and generationally shifted social acceptance, has created a perfect storm for the medical community. The emergence of this drug highlights the lack of ...
https://doi.org/10.1176/appi.focus.20150009Features
Influential Publications
Publication date: 01 July 2015
Pages341–350A major challenge in understanding substance-use disorders lies in uncovering why some individuals become addicted when exposed to drugs, whereas others do not. Although genetic, developmental, and environmental factors are recognized as major ...
https://doi.org/10.1176/appi.focus.130306Publication date: 01 July 2015
Pages356–362Mood and substance use disorders commonly co-occur, yet there is little evidence-based research to guide the pharmacologic management of these comorbid disorders. The authors review the existing empirical findings, some of which may call into question ...
https://doi.org/10.1176/appi.focus.130310Publication date: 01 July 2015
Pages363–376Objective: Buprenorphine maintenance treatment (BMT) and methadone maintenance treatment (MMT) are pharmacological treatment programs for individuals with opioid use disorders. MMT is discussed in a companion article. This article describes BMT and reviews ...
https://doi.org/10.1176/appi.focus.130309Publication date: 01 July 2015
Pages377–384Neuroethics is a developing field, concerned with addressing present and future applied ethical issues brought about directly and indirectly by neuroscience advancements. One domain where neuroscience has begun to have far-reaching ethical implications is ...
https://doi.org/10.1176/appi.focus.130308Publication date: 01 July 2015
Pages385–395Background: Smoking cessation improves physical health but it has been suggested that in vulnerable individuals it may worsen mental health. This study aimed to identify the short- and longer-term effects of stopping smoking on depression and anxiety in ...
https://doi.org/10.1176/appi.focus.130307Past Issues
View Issues Archive
Vol. 22 | No. 4
Vol. 22 | No. 3
Vol. 22 | No. 2
